Steve Cohen’s Point72 says it has perfect U.S. compliance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. ANT
6. META
7. INTC
8. JBLU
9. AAPL
10. NVDA

Go back to Steve Cohen’s Point72 says it has perfect U.S. compliance

Celator Pharmaceuticals (CPXX) Misses Q4 EPS by 1c

March 21, 2016 8:21 AM EDT

Celator Pharmaceuticals (NASDAQ: CPXX) reported Q4 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12).

The following are expected milestones for VYXEOS:

3Q 2016 New Drug Application (NDA) submission1Q 2017 Marketing Authorization Application (MAA) submissionMid-2017 Prescription Drug User Fee Act (PDUFA)... More